From January 1, 2023 to March 31, 2023, the company has repurchased 174,000 shares, representing 0.03% for CNY 3.06 million. With this, the company has completed the repurchase of 2,584,800 shares, representing 0.39% for CNY 53.06 million under the buyback announced on October 26, 2022.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.71 CNY | +0.15% | +7.19% | -28.16% |
26/04 | Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.16% | 597M | |
-1.34% | 12.64B | |
-1.64% | 8.37B | |
+0.09% | 5.37B | |
+22.42% | 5.26B | |
-0.09% | 4.58B | |
-52.84% | 3.16B | |
+20.02% | 2.89B | |
+31.92% | 2.29B | |
-2.45% | 1.91B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2022.